Genomic Labs LTD
England
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- Midland Rd, Bristol BS2 0NS, UK
- Website
- genomekey.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $2,439,742 |
| FY2026 | $0 |
| FY2025 | $1,000,000 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $2,439,742 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| To develop an integrated diagnostic platform that utilizes whole genome sequencing (WGS) to identify bacterial… | National Institute of Allergy and Infectious Diseases (NIH) | $3,439,742 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Trustees Of Boston University | 75A50122C00028 | $5,432,496 |
Similar vendors
About the company
Genomic Labs LTD is a United Kingdom-based for-profit limited liability company registered in the U.S. federal government's System for Award Management (SAM) since September 2020. The company specializes in developing advanced diagnostic technologies, with a primary focus on genomic sequencing and bacterial pathogen identification technologies. Located in Bristol, UK, Genomic Labs LTD operates as a corporate entity that provides innovative medical diagnostic solutions, particularly in the realm of infectious disease detection and antibiotic susceptibility testing.
Through federal contract awards, Genomic Labs LTD has secured a significant $3,490,083 definitive cost contract from the National Institute of Allergy and Infectious Diseases (NIAID) within the Department of Health and Human Services. The contract, awarded on September 29, 2025, focuses on developing an integrated diagnostic platform utilizing whole genome sequencing to identify bacterial pathogens and predict antibiotic susceptibility directly from blood samples. The contract, which runs through May 31, 2027, was not set aside for any specific business type and represents a critical advancement in rapid diagnostic technologies. As a sub-contractor, Genomic Labs LTD has worked with the Trustees of Boston University on contract research related to developing rapid diagnostic technologies for bacterial infections.
In terms of federal grant awards, Genomic Labs LTD has been involved in sub-grant research with the Trustees of Boston University, specifically focusing on developing rapid diagnostic solutions for sepsis. The February 16, 2021 sub-grant award details the company's efforts to create a diagnostic platform that can determine bacterial presence, identify bacterial species, and assess antimicrobial susceptibility within hours. The grant-funded research aims to overcome current clinical diagnostic limitations by combining novel bacterial DNA extraction techniques, next-generation DNA sequencing, and machine learning DNA interpretation. This work represents a significant effort to improve the speed and accuracy of bacterial infection diagnostics, particularly in time-sensitive medical scenarios like sepsis treatment.
Quick answers
Is Genomic Labs LTD registered in SAM.gov?
Yes. Genomic Labs LTD's SAM.gov registration is active through April 13, 2027.
What is Genomic Labs LTD's CAGE code?
Genomic Labs LTD's CAGE code is U1PX6, and its Unique Entity ID (UEI) is NGZ6HVXE5MX4.
How much has Genomic Labs LTD received in federal contracts?
Federal contracts obligated $1,000,000 to Genomic Labs LTD in fiscal year 2025 and $3,439,742 in fiscal years 2023 through 2027.
What is Genomic Labs LTD's most recent federal award?
Genomic Labs LTD's most recent federal contract award is To develop an integrated diagnostic platform that utilizes whole genome sequencing (WGS) to identify bacterial… (75N93025C00025), from National Institute of Allergy and Infectious Diseases (NIH), on September 29, 2025.
On GovTribe
See Genomic Labs LTD's full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors